Literature DB >> 15110969

Synthesis and biological activity of novel substituted pyridines and purines containing 2,4-thiazolidinedione.

Bok Young Kim1, Joong Bok Ahn, Hong Woo Lee, Sung Kwon Kang, Jung Hwa Lee, Jae Soo Shin, Soon Kil Ahn, Chung Il Hong, Seung Soo Yoon.   

Abstract

A series of substituted pyridines and purines containing 2,4-thiazolidinedione were designed and synthesized from their corresponding pyridines and purines. These synthesized compounds (entry no. 6a-d, 12a-e, 18a-d, 23a-c) were evaluated for their effect on triglyceride accumulation in 3T3-L1 cells in vitro and their hypoglycemic and hypolipidemic activity in the genetically diabetic KKA(y) mice in vivo. On the basis of their biological activities, 5-(4-[2-[N-methyl-(5-phenyl-pyridin-2-yl)amino]ethoxy]benzyl)thiazolidine-2,4-dione (6d) was selected as a candidate for further pharmacological studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110969     DOI: 10.1016/j.ejmech.2004.03.001

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  17 in total

1.  L-Proline functionalized magnetic nanoparticles: A novel magnetically reusable nanocatalyst for one-pot synthesis of 2,4,6-triarylpyridines.

Authors:  Ali Maleki; Razieh Firouzi-Haji
Journal:  Sci Rep       Date:  2018-11-23       Impact factor: 4.379

Review 2.  Malononitrile dimer as a privileged reactant in design and skeletal diverse synthesis of heterocyclic motifs.

Authors:  Ahmad Shaabani; Seyyed Emad Hooshmand
Journal:  Mol Divers       Date:  2018-01-03       Impact factor: 2.943

3.  Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-γ agonist, after a single oral administration in healthy female subjects.

Authors:  Min Kyu Park; Tae-Eun Kim; JaeWoo Kim; Chin Kim; Seo Hyun Yoon; Joo-Youn Cho; In-Jin Jang; Kyung-Sang Yu; Kyoung Soo Lim
Journal:  Clin Drug Investig       Date:  2014-07       Impact factor: 2.859

4.  Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studies.

Authors:  S Vijaya Laxmi; P Anil; G Rajitha; Asha Jyothi Rao; Peter A Crooks; B Rajitha
Journal:  J Chem Biol       Date:  2016-07-15

5.  Microwave-promoted facile and efficient preparation of N-(alkoxycarbonylmethyl) nucleobases--building blocks for peptide nucleic acids.

Authors:  Guirong Qu; Zhiguang Zhang; Haiming Guo; Mingwei Geng; Ran Xia
Journal:  Molecules       Date:  2007-03-19       Impact factor: 4.411

6.  Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles.

Authors:  Edna de Farias Santiago; Sheilla Andrade de Oliveira; Gevânio Bezerra de Oliveira Filho; Diogo Rodrigo Magalhaes Moreira; Paulo André Teixeira Gomes; Anekécia Lauro da Silva; Andréia Ferreira de Barros; Aline Caroline da Silva; Thiago André Ramos Dos Santos; Valéria Rêgo Alves Pereira; Gabriel Gazzoni Araújo Gonçalves; Fábio André Brayner; Luiz Carlos Alves; Almir Gonçalves Wanderley; Ana Cristina Lima Leite
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

7.  Crystal structure of N-[4-amino-5-cyano-6-(methyl-sulfan-yl)pyridin-2-yl]acetamide hemihydrate.

Authors:  Mehmet Akkurt; Kyle S Knight; Shaaban K Mohamed; Bahgat R M Hussein; Mustafa R Albayati
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-02-13

Review 8.  An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes.

Authors:  Garima Bansal; Punniyakoti Veeraveedu Thanikachalam; Rahul K Maurya; Pooja Chawla; Srinivasan Ramamurthy
Journal:  J Adv Res       Date:  2020-01-22       Impact factor: 10.479

9.  Crystal structure of (5-chloro-2-hy-droxy-phen-yl)(3-methyl-isoxazolo[5,4-b]pyridin-5-yl)methanone.

Authors:  Rajamani Raja; Nataraj Poomathi; Paramasivam T Perumal; A SubbiahPandi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-10-24

10.  Efficacy and safety of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 24-weeks: a multicenter, randomized, double-blind, parallel-group, placebo controlled trial.

Authors:  Sin Gon Kim; Doo Man Kim; Jeong-Taek Woo; Hak Chul Jang; Choon Hee Chung; Kyung Soo Ko; Jeong Hyun Park; Yong Soo Park; Sang Jin Kim; Dong Seop Choi
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.